Xoma price target raised to $123 from $117 at H.C. Wainwright
H.C. Wainwright raised the firm’s price target on Xoma (XOMA) to $123 from $117 and keeps a Buy rating on the shares after the company acquired ...
Kezar Life Sciences (KZR) Receives a Hold from H.C. Wainwright
H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on Kezar Life Sciences (KZR – Research Report) today. The company’s shares ...
Stocktwits on MSN6h
Novocure Stock Soars On Positive Pancreatic Cancer Trial Results, Retail Sentiment Surges
Shares of Novocure Ltd. skyrocketed over 55% on Monday afternoon, reaching levels last seen in August 2023, as the company ...
bovnews10h
Syros Pharmaceuticals Inc (SYRS) Stock Rated Buy by H.C. Wainwright
H.C. Wainwright has recently raised Syros Pharmaceuticals Inc (SYRS) stock to Buy rating, as announced on November 4, 2020, according to Finviz. Earlier, on September 22, 2020, Alliance Global ...
bovnews13h
Why Did H.C. Wainwright Give Energy Fuels Inc (UUUU) Stock Buy Rating?
On Friday, Energy Fuels Inc (UUUU) stock saw a modest uptick, ending the day at $7.29 which represents a slight increase of $0.49 or 7.21% from the prior close of $6.8. The stock opened at $7.1 and ...
Billionaire Ken Griffin Is Selling Palantir and Buying a Stock Wall Street Expects to Rocket 139% Higher
Thanks to the Securities and Exchange Commission, you don't have to. Artificial intelligence (AI) has been the stock market's ...
manilatimes19h
Nicox's Denali Phase 3 Trial of NCX 470 Fully Enrolled in China Earlier than Expected
Results from the NCX 470 Phase 3b Whistler Mechanism of Action trial expected in Q1 2025 ...